These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 15977989)
1. Biochemical markers and risk factors of Alzheimer's disease. Flirski M; Sobow T Curr Alzheimer Res; 2005 Jan; 2(1):47-64. PubMed ID: 15977989 [TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease. Sobów T; Flirski M; Liberski PP Acta Neurobiol Exp (Wars); 2004; 64(1):53-70. PubMed ID: 15190680 [TBL] [Abstract][Full Text] [Related]
3. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice. Xie Y; Tan Y; Zheng Y; Du X; Liu Q J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066 [TBL] [Abstract][Full Text] [Related]
4. Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid. Teunissen CE; de Vente J; Steinbusch HW; De Bruijn C Neurobiol Aging; 2002; 23(4):485-508. PubMed ID: 12009495 [TBL] [Abstract][Full Text] [Related]
5. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Butterfield DA; Lauderback CM Free Radic Biol Med; 2002 Jun; 32(11):1050-60. PubMed ID: 12031889 [TBL] [Abstract][Full Text] [Related]
6. Untangling amyloid-β, tau, and metals in Alzheimer's disease. Savelieff MG; Lee S; Liu Y; Lim MH ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614 [TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: cholesterol a menace? Mathew A; Yoshida Y; Maekawa T; Kumar DS Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455 [TBL] [Abstract][Full Text] [Related]
8. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease. Wang P; Wang ZY Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171 [TBL] [Abstract][Full Text] [Related]
9. Formaldehyde, Epigenetics, and Alzheimer's Disease. Wang F; Chen D; Wu P; Klein C; Jin C Chem Res Toxicol; 2019 May; 32(5):820-830. PubMed ID: 30964647 [TBL] [Abstract][Full Text] [Related]
10. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity. Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453 [TBL] [Abstract][Full Text] [Related]
11. Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease. Wang W; Lu L; Wu QQ; Jia JP J Alzheimers Dis; 2016 Apr; 52(3):1089-99. PubMed ID: 27079718 [TBL] [Abstract][Full Text] [Related]
13. Key Peptides and Proteins in Alzheimer's Disease. Penke B; Bogár F; Paragi G; Gera J; Fülöp L Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056 [TBL] [Abstract][Full Text] [Related]
14. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431 [TBL] [Abstract][Full Text] [Related]
15. Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade. Belkacemi A; Ramassamy C Free Radic Biol Med; 2012 Feb; 52(3):593-600. PubMed ID: 22172527 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients. Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602 [TBL] [Abstract][Full Text] [Related]
18. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]
19. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease. Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887 [TBL] [Abstract][Full Text] [Related]